Dr. Paul Insel, the distinguished professor of pharmacology and medicine at the University of California, San Diego, was our 2017 recipient of the David Lehr Research Award.

He will discuss his work on GPCRs as novel therapeutics for pancreatic cancer as this two-year award term comes to a close.